Annual ROE
-30.56%
-0.76%-2.55%
December 31, 2023
Summary
- As of February 8, 2025, PMVP annual return on equity is -30.56%, with the most recent change of -0.76% (-2.55%) on December 31, 2023.
- During the last 3 years, PMVP annual ROE has fallen by -20.97% (-218.67%).
- PMVP annual ROE is now -180.40% below its all-time high of 38.01%, reached on December 31, 2018.
Performance
PMVP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-24.20%
-2.24%-10.20%
September 30, 2024
Summary
- As of February 8, 2025, PMVP quarterly return on equity is -24.20%, with the most recent change of -2.24% (-10.20%) on September 30, 2024.
- Over the past year, PMVP quarterly ROE has increased by +6.95% (+22.31%).
- PMVP quarterly ROE is now -183.28% below its all-time high of 29.06%, reached on March 31, 2020.
Performance
PMVP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PMVP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.5% | +22.3% |
| 3 y3 years | -218.7% | +22.3% |
| 5 y5 years | -180.4% | +22.3% |
PMVP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.0% | at low | -38.0% | +22.3% |
| 5 y | 5-year | -185.0% | at low | -183.3% | +64.5% |
| alltime | all time | -180.4% | at low | -183.3% | +64.5% |
PMV Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -24.20%(+10.2%) |
| Jun 2024 | - | -21.96%(-24.6%) |
| Mar 2024 | - | -29.14%(-3.7%) |
| Dec 2023 | -30.56%(+2.6%) | -30.27%(-2.8%) |
| Sep 2023 | - | -31.15%(+0.3%) |
| Jun 2023 | - | -31.05%(+6.4%) |
| Mar 2023 | - | -29.19%(+7.1%) |
| Dec 2022 | -29.80% | -27.25%(+7.2%) |
| Sep 2022 | - | -25.41%(+10.5%) |
| Jun 2022 | - | -22.99%(+12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -20.48%(+16.8%) |
| Dec 2021 | -18.75%(+95.5%) | -17.53%(+20.2%) |
| Sep 2021 | - | -14.58%(+18.0%) |
| Jun 2021 | - | -12.36%(-2.0%) |
| Mar 2021 | - | -12.61%(+7.7%) |
| Dec 2020 | -9.59%(-126.7%) | -11.71%(-43.1%) |
| Sep 2020 | - | -20.58%(-69.8%) |
| Jun 2020 | - | -68.19%(-334.7%) |
| Mar 2020 | - | 29.06%(+54.9%) |
| Dec 2019 | 35.97%(-5.4%) | 18.76% |
| Dec 2018 | 38.01% | - |
FAQ
- What is PMV Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual ROE year-on-year change?
- What is PMV Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly ROE year-on-year change?
What is PMV Pharmaceuticals annual return on equity?
The current annual ROE of PMVP is -30.56%
What is the all time high annual ROE for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual return on equity is 38.01%
What is PMV Pharmaceuticals annual ROE year-on-year change?
Over the past year, PMVP annual return on equity has changed by -0.76% (-2.55%)
What is PMV Pharmaceuticals quarterly return on equity?
The current quarterly ROE of PMVP is -24.20%
What is the all time high quarterly ROE for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly return on equity is 29.06%
What is PMV Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, PMVP quarterly return on equity has changed by +6.95% (+22.31%)